LEK S.A secures contract for Pharmaceutical Products - successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease " - B33 - treatment

United States, April 21 -- United States based LEK S.A has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical Products - successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease " - B33 - treatment. The value of the contract is worth 2322000 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....